Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0001179110-17-004610

VP, Clinical&Translational Sc acquired 5,018 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
DeVinney Erick Wayne VP, Clinical&Translational Sc 2017-03-14 Option exercise +4,659 $0.27 $1,258 4,659 D
DeVinney Erick Wayne VP, Clinical&Translational Sc 2017-03-14 Option exercise +359 $0.27 $97 5,018 D
Derivatives
DeVinney Erick Wayne VP, Clinical&Translational Sc 2017-03-14 Option exercise · Employee Stock Option (right to purchase) +4,659 0 D
DeVinney Erick Wayne VP, Clinical&Translational Sc 2017-03-14 Option exercise · Employee Stock Option (right to purchase) +359 0 D
Loading xslF345X03/edgar.xml…